Provided by Tiger Trade Technology Pte. Ltd.

Eterna Therapeutics Inc.

0.3086
-0.0677-17.99%
Post-market: 0.3068-0.0018-0.58%16:38 EST
Volume:1.23M
Turnover:370.48K
Market Cap:2.42M
PE:-0.08
High:0.3582
Open:0.3490
Low:0.2682
Close:0.3763
52wk High:5.55
52wk Low:0.2682
Shares:7.85M
Float Shares:3.16M
Volume Ratio:1.37
T/O Rate:38.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7603
EPS(LYR):-48.9723
ROE:-2264.31%
ROA:-89.29%
PB:0.68
PE(LYR):-0.01

Loading ...

Company Profile

Company Name:
Eterna Therapeutics Inc.
Exchange:
NASDAQ
Establishment Date:
2018
Employees:
6
Office Location:
1035 Cambridge Street,Suite 18A,Cambridge,Massachusetts,United States
Zip Code:
02141
Fax:
- -
Introduction:
Eterna Therapeutics Inc., a life science company, provides mRNA cell engineering technologies. Its technologies include mRNA cell reprogramming and gene editing; NoveSlice and UltraSlice gene-editing proteins; and the ToRNAdo mRNA delivery system. The company has a license agreement with Factor Bioscience Limited. Eterna Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.

Directors

Name
Position
James Bristol
Chairman of the Board
Sanjeev Luther
Chief Executive Officer and Director and President
Elena Ratner
Director
Peter Cicala
Director
William Wexler
Director

Shareholders

Name
Position
Sanjeev Luther
Chief Executive Officer and Director and President
Sandra Gurrola
Senior Vice President, Finance